BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» FAK inhibitors reported in Plastech Pharmaceutical Technology patent
To read the full story,
subscribe
or
sign in
.
Cancer
FAK inhibitors reported in Plastech Pharmaceutical Technology patent
July 25, 2024
Plastech Pharmaceutical Technology Co. Ltd. has developed new fused tricyclic derivative acting as focal adhesion kinase (FAK) inhibitors.
BioWorld Science
Cancer
Patents
